Status:
COMPLETED
Long-term Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glaucoma Underwent Non-penetrating Glaucoma Surgery
Lead Sponsor:
Implandata Ophthalmic Products GmbH
Collaborating Sponsors:
CRO Dr. med Kottmann GmbH & Co. KG
Conditions:
Glaucoma
Open Angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the long-term safety and performance of the ARGOS-SC system.
Detailed Description
This study is designed as a prospective, open-label, multicenter, single-arm clinical investigation. This study is a follow-up study to the ARGOS-SC01 study (NCT03756662). Patients who have graduated ...
Eligibility Criteria
Inclusion
- \- Subjects of the ARGOS-SC01 study with an implanted ARGOS-SC suprachoroidal pressure sensor.
Exclusion
- N/A
Key Trial Info
Start Date :
February 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 2 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04773106
Start Date
February 20 2020
End Date
March 2 2023
Last Update
May 18 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitäts-Augenklinik Bochum
Bochum, Germany, 44892
2
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik
Mainz, Germany, 55131
3
Augenklinik der LMU München
München, Germany, 80336
4
Knappschaftsklinikum Saar GmbH, Augenklinik Sulzbach
Sulzbach, Germany, 66280